Skip to main content
NUWE
NASDAQ Industrial Applications And Services

Nuwellis Q2 Revenue Up 14%, Gross Margin Jumps to 76%, Cash Runway Extended to Q2 2027

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1.34
Mkt Cap
$4.128M
52W Low
$1.25
52W High
$235.2
52W Position info
7.2% above low
Off High info
99% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

NUWE is trading near its 52-week low of $1.25 (7.2% above the low) on light trading volume (0.2× avg).

Summary

Nuwellis reported strong Q2 2026 results with 14% revenue growth and a 20-point gross margin improvement, while post-quarter financing extended its cash runway to Q2 2027.


Key Events · Earnings and Guidance · NUWE

  • Q2 Revenue Up 14%

    Net sales reached $2.0 million in Q2 2026, a 14% increase from $1.7 million in the prior-year quarter. U.S. revenue grew 17%.

  • Gross Margin Expands to 76%

    Gross margin improved to 76% from 56% a year ago, driven by pricing adjustments, favorable product mix, and the transition to contract manufacturing.

  • Cash Runway Extended to Q2 2027

    Subsequent to June 30, 2026, the company raised approximately $6.7 million from a July financing and warrant exercises, extending its cash runway through the second quarter of 2027.

  • FDA Pre-Submission Meeting Successful

    Nuwellis advanced its proposed Aquadex label expansion to patients weighing 5 kilograms or more, following a successful FDA pre-submission meeting.


Analysis · NUWE · Industrial Applications And Services

Nuwellis reported Q2 2026 revenue of $2.0 million, up 14% year-over-year, with gross margin improving to 76% from 56%. The company raised $6.7 million after quarter-end, extending its cash runway through the second quarter of 2027. The results show meaningful commercial progress and a strengthened balance sheet, though the company remains unprofitable with a net loss of $4.8 million.

How filings like this one have moved

In the 30 days to Oct 31, 2026, 31.7% of the 1731 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, NUWE was trading at $1.34 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $4.1M. The 52-week trading range was $1.25 to $235.20. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NUWE - Latest Insights

NUWE
Oct 23, 2026, 9:18 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.520
Real-time Price: $5.80 info
Change: Reverse Stock Split info
Market Cap: $3.072M info
NUWE
Aug 26, 2026, 5:15 PM EDT
Filing Type: 424B3
Importance Score:
7
Price at Filing: $0.982
Real-time Price: $5.80 info
Change: Reverse Stock Split info
Market Cap: $3.072M info
NUWE
Aug 13, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.30
Real-time Price: $5.80 info
Change: Reverse Stock Split info
Market Cap: $3.072M info
NUWE
Aug 13, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.40
Real-time Price: $5.80 info
Change: Reverse Stock Split info
Market Cap: $3.072M info
NUWE
Aug 03, 2026, 4:35 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.58
Real-time Price: $5.80 info
Change: Reverse Stock Split info
Market Cap: $3.072M info